Sort
40,608 grants matching “prostate cancer”
FUNCTIONAL VALIDATION OF PROSTATE CANCER DRIVING MUTATIONS
$647,999Dana-Farber Cancer Institute, Inc. · · FY2011 · Department of Defense
PROSTATE CANCER BIOREPOSITORY NETWORK (PCNB)
$647,986Washington University, The · · FY2015 · Department of the Army
PSMA-targeted AuNPs for MR guided radiotherapy and radiosensitization
$647,930James Peter Basilion · Case Western Reserve University · R01 · FY2022 · CA
Quantitative Image Informatics for Cancer Research (QIICR)
$647,864Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2014 · CA
Developing Informatics Technologies to Model Cancer Gene Regulation
$647,787Clifford Meyer · Dana-Farber Cancer Inst · U24 · FY2022 · CA
DEVELOPMENT OF SMALL MOLECULE ACTIVATORS OF PROTEIN PHOSPHATASE 2A (SMAPS) FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
$647,752Icahn School Of Medicine At Mount Sinai · · FY2015 · Department of the Army
Shared Decision Making: Prostate Cancer Screening
$647,747Michael S Wilkes · University Of California At Davis · R01 · FY2006 · PH
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Gene
$647,645Dan Mercola · University Of California-Irvine · U01 · FY2011 · CA
Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis
$647,582Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
IN VIVO TARGETING AND IMAGING THE LIPOGENIC PHENOTYPE OF PROSTATE CANCER
$647,493The General Hospital Corporation · · FY2014 · Department of Defense
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
$647,487Susan S. Eggly · Wayne State University · R01 · FY2020 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$647,398Owen N Witte · University Of California Los Angeles · R01 · FY2021 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development
$647,398Owen N Witte · University Of California Los Angeles · R01 · FY2020 · CA
Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
$647,291Susan Halabi · Duke University · R01 · FY2025 · CA
MELT: Modulation of PSMA Expression for Lutetium Therapy
$647,080Thomas Hope · University Of California, San Francisco · R01 · FY2019 · CA
Integrated system for cancer biomarker detection
$646,999Massachusetts Institute Of Technology · R01 · FY2005 · CA
Small-molecule degraders of STAT5
$646,994Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
MECHANISM OF SELENIUM CHEMOPREVENTION AND THERAPY IN PROSTATE CANCER
$646,955University Of California, Davis · · FY2008 · Department of Defense
NCI NCTN- Network Lead Academic Participating Site: USC
$646,885Heinz Josef Lenz · University Of Southern California · U10 · FY2015 · CA
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
$646,885Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2024 · CA
Shared Decision Making: Prostate Cancer Screening
$646,880Michael S Wilkes · University Of California At Davis · R01 · FY2007 · PH
NOVEL THERAPY FOR PATIENTS WITH ADVANCED PROSTATE CANCER USING CODEPENDENT, TUMOR-SPECIFIC T CELLS EXPRESSING IL7 AND IL7R
$646,863Baylor College Of Medicine · · FY2011 · Department of the Army
Small-molecule degraders of STAT5
$646,849Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Preserving Erectile Function by Quantifying the Nerve-Sparing step of the Robotic Prostatectomy
$646,797Andrew Hung · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Translating gene-calcium interactions to precision medicine for colorectal cancer
$646,730Qi Dai · Vanderbilt University · U01 · FY2015 · CA